Evidence map›Paper›PMID 38332653›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Iron-Single-Atom Nanozyme with NIR Enhanced Catalytic Activities for Facilitating MRSA-Infected Wound Therapy.

Qian Liu, Xueliang Liu, Xiaojun He, Danyan Wang, Chen Zheng, Lin Jin, Jianliang Shen

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Multi-Dimensional Synergistic Engineering for Boosting Nanozyme Catalysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. pH-responsive magnetic FeMaterials today. Bio · 2025
    Article
  11. CuAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Ultrafast synthesis of L-His-FeFrontiers in bioengineering and biotechnology · 2025
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qian LiuNational Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.
Xueliang LiuThe Key Laboratory of Rare Earth Functional Materials and Applications, International Joint Research Laboratory for Biomedical Nanomaterials of Henan, Zhoukou Normal University, Zhoukou, 466001, P. R. China.
Xiaojun HeNational Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.ORCID 0009-0008-4313-6924
Danyan WangSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, P. R. China.
Chen ZhengCollege of Life and Environmental Science, Wenzhou University, Wenzhou, Zhejiang, 325035, P. R. China.
Lin JinThe Key Laboratory of Rare Earth Functional Materials and Applications, International Joint Research Laboratory for Biomedical Nanomaterials of Henan, Zhoukou Normal University, Zhoukou, 466001, P. R. China.ORCID 0000-0001-7969-5308
Jianliang ShenNational Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.ORCID 0000-0003-4351-4872
Wenzhou Medical University · CNZhoukou Normal University · CNWenzhou University · CN

Funding

National Natural Science Foundation of China 21977081Natural Science Foundation of Henan Province 232300420398Qianjiang Talents Fund of Zhejiang Province QJD20020224Science Fund for Distinguished Young Scholars of Zhejiang Province LR23C100001Wenzhou Medical University KYYW201901
6 · The paper itself

Abstract

Patients with methicillin-resistant Staphylococcus aureus (MRSA) infections may have higher death rates than those with non-drug-resistant infections. Nanozymes offer a promising approach to eliminating bacteria by producing reactive oxygen species. However, most of the conventional nanozyme technologies encounter significant challenges with respect to size, composition, and a naturally low number of active sites. The present study synthesizes a iron-single-atom structure (Fe-SAC) via nitrogen doped-carbon, a Fe-N

Indexed as

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBiofilmsHumansHydrogen PeroxideIronAnti-Bacterial AgentsHydrogen PeroxideIronantibacterial therapyironnanozymesingle‐atom catalystwound healing

Identifiers

PMID38332653
PMCPMC11022696
OpenAlexW4391691342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.